There is an error in the third sentence of the second paragraph of the Introduction. The correct sentence is: "In Puerto Rico, cancer was the second leading cause of death by 2010 \[8\], and cervical cancer accounts for 3.9% of all cancer cases \[9\]."

There are errors in [Table 1](#pone.0204759.t001){ref-type="table"}. The numbers from the 34%/13% scenario are repeated for the 50%/40% and 80%/64% scenarios. In addition, I the 80%/64% scenario, the years have an inverted order. Please see the corrected [Table 1](#pone.0204759.t001){ref-type="table"} here.
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###### Estimated cumulative incidence costs avoided since HPV4 vaccination program started, by vaccination scenario.

![](pone.0204759.t001){#pone.0204759.t001g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HPV Disease                Vaccination Scenario\    Vaccination Scenario\    Vaccination Scenario\                                                                                                                                  
                             (34% Female/13% Male)    (50% Female/40% Male)    (80% Female/64% Male)                                                                                                                                  
  -------------------------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------- -------------------------
  Genital warts-female       \$8,671,954              \$14,257,263             \$18,123,487             \$12,814,209             \$20,640,587             \$26,038,578             \$31,678,147             \$51,246,695              \$64,843,815

  Genital warts-male         \$8,108,461              \$13,440,910             \$17,091,889             \$16,223,314             \$26,604,903             \$33,770,465             \$37,975,475             \$62,669,838              \$79,764,797

  CIN1                       \$841,749                \$1,975,720              \$2,863,853              \$1,151,140              \$2,573,883              \$3,687,742              \$2,771,264              \$5,765,318               \$8,071,479

  CIN2/3                     \$4,830,393              \$13,375,935             \$20,551,689             \$6,053,998              \$16,289,155             \$24,930,480             \$13,071,331             \$32,275,160              \$48,333,370

  Cervical cancer            \$1,215,209              \$4,347,953              \$7,539,668              \$1,522,658              \$5,267,437              \$9,079,015              \$3,365,007              \$10,455,572              \$17,408,785

  ***Total Direct Costs***   ***\$23*,*667*,*766***   ***\$47*,*397*,*781***   ***\$66*,*170*,*586***   ***\$37*,*765*,*319***   ***\$71*,*375*,*965***   ***\$97*,*506*,*280***   ***\$88*,*861*,*224***   ***\$162*,*412*,*583***   ***\$218*,*422*,*246***
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
